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By impairing both function and survival, the severe reduction in oxygen availability 
associated with high-altitude environments is likely to act as an agent of natural 
selection. We employed genomic and candidate gene approaches to search for 
evidence of such genetic selection.  First, a genome-wide allelic differentiation scan 
(GWADS) comparing indigenous highlanders of the Tibetan Plateau (3200-3500m) 
with closely related lowland Han revealed a genome-wide significant divergence 
across eight SNPs located near EPAS1. This gene encodes the transcription factor 
HIF2α, which stimulates production of red blood cells and thus increases the 
concentration of hemoglobin in blood.  Second, in a separate cohort of Tibetans 
residing at 4200m, we identified 31 EPAS1 SNPs in high linkage disequilibrium that 
correlated significantly with hemoglobin concentration.  The sex-adjusted 
hemoglobin concentration was, on average, 0.8 gm/dl lower in the major allele 
homozygotes compared with the heterozygotes.  These findings were replicated in a 
third cohort of Tibetans residing at 4300m.  The alleles associating with lower 
hemoglobin concentrations were correlated with the signal from the GWADS study, 
and were observed at greatly elevated frequencies in the Tibetan cohorts compared 
with the Han. High hemoglobin concentrations are a cardinal feature of chronic 
mountain sickness offering one plausible mechanism for selection. Alternatively, as 
EPAS1 is pleiotropic in its effects, selection may have operated on some other aspect 
of the phenotype.  Whichever of these explanations is correct, the evidence for 
genetic selection at the EPAS1 locus from the GWADS study is supported by the 
replicated studies associating function with the allelic variants.  
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\body 
The high plateaus of Central Asia and the Andes were among the last areas occupied as 
Homo sapiens spread across the globe during the past 100-200,000 years.  In the case of 
the Tibetan plateau, early visitors appeared more than 30,000 years ago, and the plateau 
has been colonised for more than 10,000 years (1, 2).  The low partial pressure of oxygen 
resulting from the extreme altitude would have presented a formidable biological 
challenge to such colonists.  Individuals from low-altitude populations (European and 
Han) who move to live at high altitude suffer from a number of potentially lethal diseases 
specifically related to the low levels of oxygen (3-5) and struggle to reproduce at these 
altitudes (6-9). The hypoxia of altitude (hypobaric hypoxia) would thus have exerted 
substantial evolutionary selection pressure.  
 
The classic disease associated with long term residence at high altitude is chronic 
mountain sickness, or Monge’s disease, after Carlos Monge-M who first identified the 
condition among Andean highlanders (10). The cardinal feature is a very high 
concentration of the oxygen-carrying pigment, hemoglobin, in the blood, caused by an 
overproduction of red blood cells (excessive erythrocytosis). Tibetan highlanders are 
particularly resistant to developing chronic mountain sickness (4, 11), and exhibit little or 
no increase in hemoglobin concentration with increasing altitude, even at 4,000 m 
(13,200’) and only moderate increases beyond (12, 13).  Typically, Tibetans average 
about 1 gm/dL (10-15%) lower hemoglobin concentration in comparison with their 
Andean counterparts (14-16) or acclimatized lowlanders, such as the Han who have 
moved to altitudes above 2,500 m (4, 17-23).  This suggests that Tibetans have evolved a 
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blunted erythropoietic response to high-altitude hypoxia.  The induction of erythrocytosis 
by hypoxia involves the hypoxia-inducible factor (HIF) family of transcription factors 
and, in particular, EPAS1 (or HIF2α) (24, 25).   
 
Three independent studies, but with mutually reinforcing results, were performed by 
groups which have since come together to form The High-Altitude Genetics Consortium 
with the aim of reporting on the findings.  The first study was a genome-wide allelic 
differentiation scan which compared SNP frequencies of a Yunnan Tibetan population 
residing at 3,200-3,500 m with the HapMap Phase III Han sample.  Mitochondrial, Y 
chromosome and autosomal DNA evidence all suggest a north or east Asian origin for 
modern Tibetans (1, 26-28).  Thus, the Han comprise a lowland population that is closely 
related to the Tibetans, but which has not undergone selection for high-altitude 
adaptation.  From this study, a signal of selection close to EPAS1 was identified at a 
genome-wide level of significance. The second study comprised a candidate gene 
analysis of EPAS1 in a separate sample of Tibetans from 4,200 m on the Tibetan plateau 
and identified a significant association between genotype and hemoglobin concentration, 
with the major alleles associating with the lower hemoglobin levels. These alleles were 
present at low frequency in the Han. The third study replicated the hemoglobin 
association in an independent sample of Tibetans from 4,300 m. 
 
Results 
Genome-wide Allelic Differentiation Scan. A genome-wide allelic differentiation scan 
(GWADS) was used to compare a cohort of Tibetan residents (n=35) sampled from four 
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townships at altitudes of 3,200-3,500 m in Yunnan Province, China with HapMap Phase 
III Han individuals (n=84).  We postulated that any marked differences in SNP 
frequencies between the Yunnan Tibetan and the HapMap Han populations could reflect 
a history of divergent selection on functional variation that contributes to increased 
survival at high altitude. (See Supporting Information for detailed methodology.) Of the 
502,722 SNPs that were included in the analysis, eight SNPs emerged as having genome-
wide significance (p values ranging from 2.81x10-7 to 1.49x10-9), all located within 235 
kb on chromosome 2 (Fig. 1, Fig S4 and Table S1).  
 
All eight GWADS significant SNPs were in high pairwise linkage disequilibrium in the 
Yunnan sample (0.23< r2 <0.82), forming an extended haplotype with a frequency of 
46% in the Yunnan Tibetan sample but only 2% in the Han sample (estimated via an 
expectation-maximization algorithm using Haploview software (29, 30)). The SNPs lie 
between 366 bp and 235 kb downstream of EPAS1 but, as we show below, the region of 
high linkage disequilibrium extends into EPAS1 itself. In addition to this genome-wide 
significant finding relating to EPAS1, evidence for other signals of selection was also 
found.   Regions of sub-genome wide significance were in close proximity to other genes 
of the HIF pathway and present intriguing targets for follow-up studies (see Supporting 
Information for further details). 
 
Candidate Gene Study for EPAS1. Independent of the GWADS study, a candidate gene 
study (based on the pathway linking hypoxia, EPAS1 and erythropoietin) addressed the 
functional consequence of EPAS1 variants by testing for association with hemoglobin 
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concentration in a sample of 70 Tibetans residing at 4,200 m in Mag Xiang, Xigatse 
Prefecture in the Tibet Autonomous Region, China. One hundred and three non-coding 
SNPs across the EPAS1 gene were selected for genotyping. Of these, 49 had a minor 
allele frequency ≥5%, and were thus amenable to regression analysis (see methods) that 
identified 31 SNP sites significantly associated with hemoglobin concentration (Fig. 2 
and Table S3).  The major (most frequent) allele of every significant SNP was associated 
with lower hemoglobin concentration.  After adjusting for sex differences, individuals 
who were homozygous for the major allele had an average hemoglobin concentration that 
was 0.8 + 0.15 (SD) gm/dL (range from 0.3 to 1.0 gm/dL) lower than individuals who 
were heterozygous for the major allele. Conditional linear regression analyses showed 
that once the most significant SNP (rs4953354) was included, no significant 
improvement in fit was obtained after Bonferroni correction by adding any other SNP, 
consistent with a single-causal-variant model.  Many of the SNP sites were in high 
linkage disequilibrium (Fig. 2).  Genotypes for the eight GWADS significant SNPs were 
available on 29 of the 70 individuals in the Mag Xiang cohort, too few to show statistical 
association with hemoglobin concentration. However, all eight GWADS SNPs were 
highly correlated (0.54 < r2 < 1) with variants associating with hemoglobin concentration 
in the complete Mag Xiang cohort (see Table S4). Thus, the genome-wide and the 
candidate-gene analyses can be linked, with the latter study demonstrating that there is a 
phenotype associated with the signal of selection..  
 
Replication of Candidate Gene Study for EPAS1. We replicated the association of 
EPAS1 SNPs with hemoglobin concentration in another sample of 91 Tibetans residing at 
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4300m in Zhaxizong Xiang, Xigatse Prefecture, China.  Of the 49 Mag Xiang SNPs with 
a minor allele frequency ≥5%, 48 were successfully genotyped in the Zhaxizong Xiang 
sample.  Of these, 45 sites had a minor allele frequency ≥5% and 32 sites were 
significantly associated with hemoglobin concentration. After adjusting for sex 
differences, individuals who were homozygous for the major allele had an average 
hemoglobin concentration that was 1.0 + 0.14 (SD) gm/dL (range from 0.5 to 1.2 gm/dL) 
lower than individuals who were heterozygous for the major allele (Fig. 3 and Table S3). 
Twenty-six SNPs were associated with hemoglobin concentration in both samples and 
the direction of the effect was the same. Conditional linear regression again found that, 
after including the most significant SNP (rs13419896), no further SNPs were significant 
after Bonferroni correction.   This was also the case if the most significant SNP from the 
Mag Xiang sample (rs4953354) was used instead of rs13419896.  Genotypes for the eight 
GWADS significant SNPs were available on 89 samples from the Zhaxizong Xiang 
cohort. Three of these SNPs correlated significantly with hemoglobin concentration 
(Table S4), thus supporting the association of a phenotype with the signal of selection 
that has been obtained from this area of the genome.   
 
Comparing allelic frequencies between the two Tibetan samples and the HapMap Han 
sample, we note that the largest allele frequency differences occur at the EPAS1 SNP 
sites that are associated with low hemoglobin concentration (Fig. 4).  Linkage 
disequilibrium (LD) among these 26 SNP sites was also elevated in the two Tibetan 
cohorts compared with the HapMap Han (Fig. S5).   
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Discussion 
The results from the GWADS study revealed a level of allele frequency differentiation 
near EPAS1 that far exceeds the genome-wide average (Fig. 1). The association studies 
demonstrated that the SNP variants that were at higher frequencies within the Tibetan 
population were associated with lower hemoglobin concentrations. As large genome-
wide association studies of the determinants of hemoglobin concentration in other 
populations at low altitude have failed to detect a signal associated with EPAS1 (31-34), 
our results suggest either that there is an allelic variant that is quite specific to the Tibetan 
population or that the allelic variant is quite specific to moderating hemoglobin 
concentration only under conditions of high altitude. Such specificity of effect in relation 
to Tibetan highlanders is in keeping with a model of selection pressure on EPAS1 under 
the stress of high-altitude hypoxia.  Interestingly, a comparison between the HapMap Han 
and Andean highlanders – both of whom have a vigorous erythropoietic response (15) – 
did not detect selection at the EPAS1 locus (35). It should be noted however that the 
Andean study (35) applied a different array of methodologies to detect selection and 
overlapping results are not necessarily expected, given the differing nature of the 
selection signals which particular techniques are powered to detect.  It is also possible 
that the Andean and Tibetan populations have developed different genetic adaptations to 
the hypoxia of high altitude given the differences in physiology that are known to exist 
between these populations (13). 
 
The association studies revealed that EPAS1 polymorphism makes a large contribution to 
variation in hemoglobin concentration. After controlling for sex, the average difference in 
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hemoglobin concentration between major allele homozygotes and heterozygotes was 
53% of one standard deviation in the Mag Xiang sample and 50% in the Zhaxizong 
Xiang sample. In absolute terms, these differences were several fold larger than for any 
of the determinants of hemoglobin concentration in populations residing at low altitude 
(31-34). Our findings are, however, consistent with previous high estimates of heritability 
(h2) for hemoglobin concentration of 0.66 among Tibetans at 4,850 – 5,450 m (36) and of 
0.86 among Tibetans at 3,800-4,065 m (15). These values estimate the proportion of 
additive genetic variation relative to total phenotypic variance.  The combined findings of 
our association and conditional linear regression analysis are consistent with a model in 
which a single causal variant at the EPAS1 locus accounts for a substantial proportion of 
the heritability.  Under this model, hemoglobin-associating SNPs should be interpreted as 
markers and are presumed to have differentiated because they are closely linked to an as 
yet to be identified causal variant.  Functional studies will be required to identify how this 
variation works to restrain the hematopoietic response. 
 
We have described a signal of natural selection on or near EPAS1 which is associated 
with a blunting of the normal erythropoietic response to hypoxia. As EPAS1 is 
pleiotropic, other responses to hypoxia may be similarly affected. Some insight into these 
may be given by studies of a few individuals/families, living at low altitudes, who have 
been reported to have gain of function mutations in EPAS1 (37-40). As expected, these 
individuals exhibit excessive erythrocytosis, but they also appear to be particularly 
susceptible to thrombotic events and to developing pulmonary hypertension - although 
the total number of cases reported is small. A larger number of cases have been reported 
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for the slightly less specific genetic disorder of Chuvash Polycythemia, where 
homozygosity for hypomorphic alleles for VHL results in elevated levels of both HIF1α 
and EPAS1/HIF2α (41). The phenotype for Chuvash Polycythemia appears very similar 
to that for the specific EPAS1 gain of function mutations, with excessive erythrocytosis, 
an excess risk of thrombotic events at a young age and pulmonary hypertension (42-45). 
In both conditions, the excessive erythrocytosis is generally managed by venesection in 
the belief that this may reduce the incidence of thrombotic events. 
 
The clinical similarity between the phenotypes of these genetic disorders and chronic 
mountain sickness is striking. Indeed, it caused one group of investigators to observe in 
respect of the EPAS1 gain of function mutations that “it raises the possibility that 
polymorphic variation in HIF2α [EPAS1] contributes to the marked differential 
susceptibility to erythrocytosis, reduced plasma volume and pulmonary hypertension in 
humans at high altitude” (39). Chronic mountain sickness occurs among Tibetans at a 
lower prevalence than Han lowlanders (1.2% as compared with 5.6%) living in the Tibet 
Autonomous Region (4, 46). Chronic mountain sickness remains at that low level 
throughout adulthood among Tibetans but, in Peruvians, prevalence increases with age 
from ~13 % in 20-39 year olds to ~36% in 55-69 year olds at 4,300 m (47). In Andeans, 
excessive erythrocytosis at high altitude has been associated with significant pulmonary 
hypertension (48), an increased risk of stroke (49) and also an increased risk of poor 
outcome in pregnancy (stillbirth, preterm birth or small for gestational age birth) (50).  
These findings provide insight into some of the sources of elevated morbidity and 
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mortality on which selection may have operated to influence allelic frequencies for 
EPAS1 among the early colonizers of the Tibetan plateau. 
  
Although the similarity between chronic mountain sickness and the EPAS1 gain of 
function phenotype in lowlanders is striking, there nevertheless may be other aspects to 
the phenotype that are not revealed at low altitude, but are only revealed at high altitude 
when oxygen availability is also limited. In particular, EPAS1 plays very important, if 
still poorly understood, roles in both placental and embryonic development (51-54), and 
possibly also in the pathogenesis of fetal growth restriction (55).  It is well recognised 
that reproductive success is more difficult at high altitude than at low altitude, and more 
difficult for non-natives than natives (6). For example, pre- and post-natal mortality are 
3-fold higher in the Han than in the Tibetans, and birth weight is significantly lower (56).  
This may relate in part to the presence of greater uterine arterial blood flow and lower 
hemoglobin concentration in the Tibetans (57, 58).  As such, natural selection on EPAS1 
may also have operated via effects during pregnancy that affect both pre- and post-natal 
mortality.  
 
In conclusion, this study provides evidence for natural selection in Tibetan highlanders at 
a specific human gene locus. The finding is further supported by a demonstration, in two 
independent samples, that genetic variation at this locus has an associated phenotype. The 
known physiological roles associated with this gene locus provide insight into some of 
the factors that are likely to have influenced human adaptation and survival following 
colonization of the Tibetan Plateau. 




Materials and Methods   
 
Human Volunteers: Ethics and Consent. This study was approved by the ethics 
committees of the Yunnan Population and Family Planning Institute (Kunming, China); 
the Beijing Genomics Institute at Shenzhen; the Beijing Institute of Genomics, Chinese 
Academy of Sciences and Case Western University (Cleveland, Ohio). All work was 
conducted in accordance with the principles of the Declaration of Helsinki. All 
participants were recruited after obtaining informed consent.  
 
Sample Collection. Sampling was conducted in three geographic regions of China 
approximately 1,500 miles apart.  They were: i) the North Western region of Yunnan 
province (28°26’N  98°52'E); ii) Mag Xiang, Xigatse Prefecture, Tibet Autonomous 
Region (29°15’N  88°53'E) and iii) Zhaxizong Xiang, Xigatse Prefecture, Tibet 
Autonomous Region (28° 34’ N 86° 38’E). Genotypic data from the HapMap Phase III 
Han population were also included in this analysis. Further details on sample collection 
are given in the Supporting Information. 
 
Genotyping. All genotyping was conducted at the Beijing Institute of Genomics. The 
whole genome genotyping was conducted using the Illumina Veracode platform and 610-
Quad high throughput genotyping chips. Genotyping within EPAS1 was conducted using 
a customer-designed Illumina GoldenGate assay (384 SNP plex) for all samples from 
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Mag Xiang, and some of the samples from Zhaxizong Xiang. The remainder of the 
samples from Zhaxizhong Xiang were genotyped using MassARRAY assays. Further 
details of these and the quality control procedures are given in the Supporting 
Information. 
 
Phenotyping:  Hemoglobin concentration was measured in duplicate immediately after 
provision of a venepuncture blood sample by individuals in the Mag Xiang sample (59).  
Individuals were screened with the aim of including only healthy, native residents.  
Excluded were individuals who had anemia (men and women with hemoglobin 
concentrations below 13.7 gm/dL and 12 gm/dL, respectively), hypertension, fever, poor 
lung function, extreme hypoxemia, or who were currently or recently pregnant, or who 
had symptoms or medication indicative of heart or lung disease.  The Zhaxizhong Xiang 
sample was obtained in the course of a health survey and included all volunteers who 
were native residents.   
 
Statistical Analysis: GWADS. In order to identify variation between the Yunnan 
Tibetan and the HapMap Han populations, we calculated SNP-by-SNP chi-squared 
statistics for allele frequencies and corrected for background population stratification 
through a genomic control procedure (30). This approach allows genome-wide significant 
signals of allele frequency differentiation to be readily declared by examining genomic 
distributions of chi-squared values in the sample of ~500,000 SNPs. A threshold of 
genome-wide significance was set at at 5 x10-7 (60).   A full description of the method, 
including a simulation for two populations with a degree of genomic divergence equal to 
  16 
 
that between the Yunnan Tibetan and HapMap Han populations, is given in the 
Supporting Information (Figures S2 and S3). 
 
Statistical Analysis: Candidate Gene Studies.  Candidate gene association analysis of 
EPAS1 SNP genotype with hemoglobin concentration phenotype was performed 
separately in the two Tibet Autonomous Region samples. Mean characteristics for these 
populations are given in Table S2. For each SNP, a linear additive genetic model was 
fitted with hemoglobin concentration as the response variable, the SNP as the predictive 
variable (entered as a numerical variable - 1, 2, 3 - corresponding  to the three genotypes 
sorted by descending allelic frequency)  and with gender as a covariate. The p-values of  
the likelihood ratio test were obtained from a comparison with the null model (i.e, only 
gender in the model). The estimated difference stands for the increase in the sex-adjusted 
mean with the addition of one copy of the minor allele taking the most frequent 
homozygous genotypes as the reference. Unless otherwise stated, an adjustment for 
multiple comparisons was implemented by controlling the false discovery rate at less than 
0.05 across the EPAS1 gene. The R language and environment (R Project for Statistical 
Computing http://www.r-project.org ) was used for all related analysis and graphics.  
Conditional linear analyses were undertaken by including a specified SNP as an 
additional covariate in the model and were implemented using plink 
(http://pngu.mgh.harvard.edu/~purcell/plink/). 
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Figure Legends:  
 
Fig. 1.   A genome-wide allelic differentiation scan that compares Tibetan residents at 
3,200-3,500 m in Yunnan Province, China with HapMap Han samples.  Eight SNPs near 
one another and EPAS1 have genome-wide significance.  The horizontal axis is genomic 
position with colours indicating chromosomes. The vertical axis is the negative log of 
SNP-by-SNP p values generated from the Yunnan Tibetan vs HapMap Han comparison. 
The red line indicates the threshold for genome-wide significance used (p=5x10-7). 
Values are shown after correction for background population stratification using genomic 
control. 
 
Fig. 2.  Sex-adjusted hemoglobin concentrations and allelic variation in EPAS1 SNPs in a 
Tibetan sample from Mag Xiang (4,200 m), Tibet Autonomous Region, China. Values 
were, on average, 0.8 gm/dL lower for individuals who were homozygous for the major 
alleles compared with those who were heterozygous. The top panel shows the results of 
testing variants at 49 SNPs with a minor allele frequency ≥5% for genotypic association 
with sex-adjusted hemoglobin concentration.  The middle panel displays the estimated 
hemoglobin concentration difference (mean + 95% confidence interval) between the 
major allele homozygote and heterozygote genotypes at each SNP. Filled circles 
represent SNPs detected as having a significant association with hemoglobin 
concentration while controlling the false discovery rate < 0.05 across the EPAS1 locus.  
Open diamonds represent SNPs without significant association. 
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Fig. 3.   Sex-adjusted hemoglobin concentrations and allelic variation in EPAS1 SNPs in 
a Tibetan sample from Zhaxizong Xiang (4,300 m), Tibet Autonomous Region, China. 
Values were, on average, 1.0 gm/dL lower for individuals who were homozygous for the 
major alleles compared with those who were heterozygous The top panel shows the 
results of testing variants at 45 SNPs with a minor allele frequency ≥5% for genotypic 
association with sex-adjusted hemoglobin concentration. The middle panel displays the 
estimated hemoglobin concentration difference (mean + 95% confidence interval) 
between the major allele homozygote and heterozygote genotypes at each SNP. Filled 
circles represent SNP detected as having a significant association with hemoglobin 
concentration while controlling the false discovery rate < 0.05 across the EPAS1 locus.  
Open diamonds represent SNP without significant association. The bottom panel 
illustrates the pairwise linkage disequilibrium measured as r2 between SNPs. 
 
Fig. 4. Differences in allelic frequency at SNPs within EPAS1 between the HapMap Han, 
Mag Xiang and Zhaxizong Xiang cohorts. The horizontal axis is SNP position according 
to build 36.1.  The vertical axis is allelic frequency, with the allele selected for display as 
the one occurring most frequently in the Mag Xiang cohort.  Blue squares denote data for 
HapMap Han; red circles denote data for Mag Xiang Tibetans; green triangles denote 
data for Zhaxizong Xiang Tibetans. Filled symbols denote those SNPs having significant 
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associations with hemoglobin in both Mag Xiang and Zhaxizong Xiang cohorts; open 
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Natural selection on EPAS1 (HIF2α) associating with low 





Participant Sample 1: Yunnan Tibetans. Data collection took place in June 2007. 
Samples from the Yunnan province came from two districts (Shangri-La and De Qin) at 
altitudes from 3200-3500m, from four townships (Ben Zi Lan 28°16'6.04"N  
99°12'59.57"E, Jian Tang 27°50'20.75"N  99°45'49.42"E, Adun Zi 28°26'53.50"N  
98°53'44.21"E and Ju Shui 28°26'28.45"N  98°52'35.38"E). The population ethnicity of 
each of these townships is heavily Tibetan. Participants were recruited based on ethnicity 
as recorded by the Yunnan province Family Planning Institute. Participants were also 
asked to declare grand-parental ethnicity during the recruitment process.  Each participant 
provided a saliva sample (using Oragene DNA collection kits) and basic health 
phenotype details. We recorded the following for each participant: family details, weight, 
height, heart rate, blood pressure, heart disease status 
respiratory/digestive/urinary/endocrine health, and basic altitude sickness details. A set of 
48 individuals was selected for genome scanning. After exclusions for quality control 
(QC) and relatedness, data from a total of 35 individuals remained for analysis. 
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Participant Sample 2: Mag Xiang Tibetans. Data collection took place from June to 
August 2002 in Mag Xiang , a rural agropastoral district of Xigatse Prefecture at 4200m, 
Tibet Autonomous Region. Details on this collection have been reported previously (1, 
2).  All participants were 18-55 years of age, normotensive, nonanemic, nonsmoking (by 
self-report and verification of exhaled carbon monoxide level), healthy (by self-report), 
not pregnant (by self-report) and had normal pulmonary function. They were all born and 
raised in Mag or nearby villages and were of Tibetan ethnicity.  Hemoglobin 
concentration was determined in duplicate using the cyanmethemoglobin technique 
(Hemocue Hemoglobinometer, Hemocue AB, Angelholm, Sweden), immediately after 
drawing a venous blood sample.  DNA samples were collected for each study participant 
from buccal cells obtained using by the mouthwash method (3). Sufficient DNA was 
isolated for 57 of the study participants from this procedure.  An additional 17 study 
participants provided DNA samples from buccal and white cells in saliva obtained using 
the Oragene DNA Self-Collection kits (DNA Genotek, Ontario, Canada) in 2007, 
bringing the total number of subjects with sufficient DNA to 74.  After exclusions due to 
quality control, genotypic and phenotypic data were available for 70 people. 
 
Participant Sample 3: Zhaxizong Xiang Tibetans. Data collection took place in June 
2007 in Zhaxizong Xiang, a rural agropastoral district of Xigatse Prefecture, at an altitude 
of 4300m at the base of Mt. Qomolangma.  Adults representing about 10% of the total 
population were recruited for a health survey and collection of phenotypic and genetic 
information.  Study participants were 18-55 years of age, unrelated, high-altitude native 
Tibetans whose families had lived in the villages for at least two generations.  A subset of 
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92 participants with values of hemoglobin and blood oxygen saturation within normal 
ranges was selected for inclusion in the present study.  Hemoglobin and other blood 
parameters were measured with an Auto Hematology Analyzer BC-2800 (Shenzhen 
Mindray Bio-Medical Electronics Co. Ltd).    DNA was isolated from blood samples 
using QIAGEN kits. After exclusions due to quality control, complete genotypic and 
phenotypic data were available for 91 people. 
 
Participant Sample 4: HapMap Han. Data for the Han population were accessed from 
the HapMap project (HapMap3, release 2). We selected the HapMap Han as a lowland 
population with common ancestry, as Y chromosome and mitochondrial DNA studies 
have illustrated genetic continuity between numerous different Tibetan groups and the 
Han: Genetic and archaeological evidence suggests that the majority of Tibetan lineages 
can trace their ancestry to post Paleolithic and Neolithic migrations from Northern China 
approximately 10,000 years ago (4, 5). Genomic analysis was conducted on the 503,722 
SNPs common to both HapMap and Yunnan Tibetan datasets. 
 
Whole Genome SNP Genotyping. Genotyping of the Yunnan Tibetan samples (Sample 
1) was conducted using the Illumina Veracode platform and 610-Quad high throughput 
genotyping chips. Forty-eight samples from the Yunnan collection were genotyped 
(broken down according to township as: Ben Zi Lan n = 15, Jian Tang n = 20, Adun Zi n 
= 6, Ju Shui n = 7).   
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All samples were brought into a single BeadStudio file using the standard Illumina 
cluster file. Samples were checked for very low intensity and for call rates <95%, and all 
samples passed this first QC step.  All SNPs that had a call frequency below 100% were 
then re-clustered. Samples were then checked for call rates <98% after the re-clustering, 
and again all samples passed this second QC step.  Next, a “1% rule” was applied where 
all SNPs that had a call frequency below 99% were deleted. Any SNPs where more than 
1% of samples were not called or were ambiguously called were deleted (SNPs with 
many samples not called (or potentially miscalled) can lead to false positives in statistical 
associations).   We introduced the following procedure to prevent errant calls (from SNP 
re-clustering) from entering the final report. The SNP data are screened within 
BeadStudio by looking at two criteria. First, all SNPs with a cluster separation value 
below 0.3 are manually checked to ensure correct calls. Many of these SNPs can be 
manually fixed, but some have to be deleted. Next, all SNPs (excluding X chromosome 
SNPs) with a Het Excess value between -1.0 to -0.1 and 0.1 to 1.0 are evaluated to 
determine if the raw and normalized data show a clean call. Any SNP cluster that doesn’t 
appear normal is deleted. This includes SNPs that appear to show a deletion (hemizygotes 
and homozygous deletion). The rationale behind this is to avoid artifacts from either the 
chemistry or an interfering SNP during hybridization. These procedures resulted in a 
97.5% success rate of genotyping calls. 
 
To minimise problems arising from hidden population and family structure in the Yunnan 
sample, we removed 13 individuals using the following quality control steps.  First, we 
computed pairwise identity-by-descent calculations for all pairs of individuals (Pi_Hat 
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calculation in PLINK (6)). We identified 6 families defined by members sharing greater 
than third degree relatedness.  Four of these involved two individuals, one involved 5 
individuals, and one involved 6 individuals.  We removed the fewest number of 
individuals consistent with breaking all first and second degree relationships 
(Pi_Hat<0.17). Where a choice of individuals was possible, we picked the sample with 
the highest inbreeding coefficient (a measure of average genome-wide homozygosity) for 
removal.  This resulted in 10 exclusions. Next, we removed two individuals with 
inbreeding coefficient values greater than 0.09 (appearing as outliers on a histogram of 
inbreeding values). Finally, we removed one individual who appeared as a clear outlier 
from PCA analysis of the genotype data. We then removed 139 SNPs with less than 95% 
coverage across the reduced sample of 35 individuals. The genotype dataset complied 
with that expected of a population in Hardy Weinberg equilibrium. 
 
For the GWADS analysis described later, we downloaded HapMap Phase III Han 
Chinese data (release 2, accessed 2 Feb 2009, CHB sample, n=84, typed on both Illumina 
1M and Affymetrix 6.0 platforms) from www.hapmap.org.  We merged this dataset with 
our post-QC Yunnan dataset, and restricted to those SNPs common to both datasets 
(n=504450).  We removed 726 symmetric SNPs (A/T or C/G alleles) and 2 SNPs with 
ambiguous map positions.  Finally, we removed 94 SNPs that emerged as singletons from 
GWADS analysis.  These were SNPs with a very high apparent allelic frequency 
difference between the Yunnan Tibetan and HapMap Han samples, but with no support 
for this signal from neighbouring SNPs in the region. 
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Candidate Gene Genotyping in the Mag Xiang Discovery Sample. A GoldenGate 
assay was used for all 74 samples from Mag Xiang (sample 2). EPAS1 was one of 11 
candidate genes in a customer-designed Illumina GoldenGate assay (384 SNP plex).  For 
SNP determination, first, all haplotype-tagging SNPs for the EPAS1 gene were chosen 
from genotypes of Asian populations (HapMap Han/Beijing and Japanese/Tokyo) of the 
HapMap project (Phase II dataset).  In addition, non-overlapping tag SNPs of the 
HapMap African population (Yoruba) were included to increase genotyping coverage. In 
total, 103 SNPs across the EPAS1 gene were selected for genotyping. 
 
BeadStudio was used for genotype determination. A GenCall score of 0.25 and GenTrain 
score of 0.55 were applied for initial QC screening.  Genotypes were then verified by 
manual clustering; loci whose homo- and heterozygote clusters did not separate clearly 
were eliminated. Data from 73 individuals passed QC. Of the 103 EPAS1 SNPs in the 
GoldenGate assay, 96 SNPs passed QC, of which 49 SNPs were common with a MAF ≥ 
0.05.  
  
Of the 73 individuals whose genotyping passed quality control, phenotypic data were 
missing in one individual and  measurements of hemoglobin concentration in a further 
two individuals. Therefore the discovery analysis was conducted on 49 common SNPs of 
the EPAS1 gene in 70 individuals of Mag Xiang cohort.  
 
Candidate Gene Genotyping in the Zhaxizong Xiang Replication Sample. 
GoldenGate and MassARRAY assays were used to genotype the EPAS1 gene on a total 
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of 92 individuals from Zhaxizong Xiang (sample 3). With the same quality control 
procedure as described above, individual GoldenGate assays were carried out on a set of 
44 samples, and another 48 samples were genotyped by GoldenGate assay as pooled 
groups in order to increase sample usage.  Minor allele frequency was then calculated 
from the genotype data from all 92 samples, and this gave a total of 58 SNPs of the 
EPAS1 gene with a MAF ≥ 0.05. These SNPs were selected for further genotyping on 
each individual sample from the 48 previously pooled samples using MassARRAY 
analysis.  Typer 4.0 software (Sequenom, Inc.) was used to collect genotype data after 
clustering.   A specificity of 0.90 and sensitivity of 0.95 were set to cluster all loci. After 
clustering, all samples with call rates less than 80% or loci with call frequencies less than 
95% were eliminated. Next, SNPs with homo- and heterozygote clusters not clearly 
separated were removed manually.  One entire sample and six SNP loci were excluded by 
QC; this gave 52 SNPs in 47 individuals with a call rate of 99.67%.  
 
Combining the data from the 47 individuals genotyped by MassARRAY with the data 
from the 44 individuals individually genotyped by GoldenGate assay resulted in 
genotypes for 52 SNPs from 91 samples from Zhaxizong Xiang.   Further alignment of 
the 52 SNPs with the successful SNPs of Mag Xiang samples in discovery analysis 
yielded 48 overlapping SNPs. Of these 48 SNPs, 45 with common loci (MAF ≥ 5%) were 
analyzed in 91 Zhaxizong Xiang samples in the replication study. 
 
Following the quality control procedure outlined above, the eight significant SNPs 
identified in the genome-wide allelic differentiation scan (see below) were also 
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genotyped using the MassARRAY system. A subset of 30 individuals from Mag Xiang 
and all 92 individuals from Zhaxizong Xiang were analyzed.  One sample from Mag 
Xiang and 3 samples from Zhaxizong Xiang were eliminated after quality control 
analysis. Call rates were 100% and 99.72% in the 29 and 89 samples analyzed from Mag 
Xiang and Zhaxizong Xiang, respectively. 
 
 
SI Statistical Analysis and Results 
 
Genome-wide Allelic Differentiation Scan (GWADS). Here, we present the method 
used for conducting differential scans which is based on approaches originally developed 
for genome-wide association studies.  Existing methods for detecting differential 
selection rely on the calculation of statistics such as FST (7) or iHS (8), which are intuitive 
but lack any simple distributional theory.  This prevents the reliable testing of genome-
wide significance of these statistics.  Typically, one must either resort to genome-wide 
simulation, which limits the conclusions to the demographic model used with its 
particular assumptions, or on reporting the extreme tail values of a genome-wide 
distribution, which abrogates genome-wide significance testing altogether since there will 
always be, for example, a 5%, 1% or 0.1% tail to every distribution. 
 
In particular, we use SNP-by-SNP allelic chi-squared statistics, calculated between two 
population samples, as an appropriate differentiation statistic, and we correct for 
background levels of differentiation using genomic control.  This allows for unusually 
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differentiated loci to be declared as genome-wide significant.  Allelic (or allele-counting) 
chi-squared statistics are not usually used for genetic association testing because 
departures from the null under simple genetic risk models typically result in equal power 
for the allelic and Cochran Armitage trend tests, and the latter enjoys the advantage that 
the assumption of Hardy Weinberg equilibrium is not required (9).  However, allelic tests 
are entirely appropriate for tests of population differentiation, since departures from the 
null under simple population genetic models for this scenario typically result in greater 
power for allelic tests over trend tests, and departures from the assumption of Hardy 
Weinberg equilibrium (which need only hold within each population for the test to be 
valid) can in any case be corrected for by genomic control. 
 
Genomic control was proposed by Devlin and colleagues (10), but the distributional 
theory which justifies it came in a later paper by Devlin and colleagues (11).  They 
showed that, under very general conditions, one can expect the allelic chi-square statistic 
of a SNP typed in two population samples to be inflated in the presence of population 
stratification by an amount that depends on sample size, FST and inbreeding coefficients, 
but not on the allele frequency of the SNP in question.  The amount of chi-square statistic 
inflation in other SNP loci can therefore be used as a yardstick to gauge the significance 
of the inflation seen in any one SNP of interest.  In a genome-wide context, averaging all 
SNPs in a genome-wide panel allows for the calculation of an inflation factor, lambda, 
which represents the ‘background’ population level of differentiation between two 
populations. The corresponding inflated chi-square distribution (or equivalently the 
standard chi-square distribution, if the test statistic is first divided by lambda) represents 
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an appropriate distribution from which to test the genome-wide significance of any one 
observed chi-square statistic. Since the same lambda is applied to all SNPs, genomic 
control is only capable of correcting for background differentiation, and this property is 
seen as a failing of the method in the context of genetic association since it is possible to 
envisage highly differentiated SNPs that may still confound an association test (12).  
However, in a GWADS it is precisely these unusual, highly differentiated SNPs that one 
wishes to detect, as selection represents the best hypothesis to account for such cases. 
 
The distributional theory presented by Devlin et al (2001) makes certain normality 
assumptions that do not hold exactly for the case of only two populations (11).  
Furthermore, genomic control has not been widely investigated under a combination of 
high FST (envisioned for GWADS, but unlikely to hold for well designed association 
studies) and the extremely large chi-square values necessary for testing genome-wide 
significance.  We therefore confirmed the effectiveness of genomic control via 
simulation, as described below.  
 
Fig. S1 is a quantile-quantile (QQ) plot summarizing the results of GWADS, applied to 
all autosomal SNP loci, for the Yunnan Tibetan versus HapMap Phase 3 Han samples.  
The red line is where values are expected to fall if there is no population differentiation 
between these two samples.  The green line is where values are expected to fall if all loci 
were subject to the same level of background differentiation between the two samples, 
using Genomic Control theory and using the robust median method of Devlin & Roeder 
(10) to estimate lambda (there are several methods for calculating lambda, but all 
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typically converge to the same value as the number of SNPs used for estimation grows 
large, as is the case here).  The two blue lines represent a check on the validity of the 
Genomic Control result based on simulation.  These are chi-square values obtained from 
two sets of 500,000 SNPs that were simulated under a Balding-Nichols model (13) using 
an FST value of 0.0088 (equal to that observed between the Yunnan Tibetan and HapMap 
Han samples) and using a Beta (0.888,0.888) distribution to draw the ancestral allele 
frequency of each SNP (again derived from the empirical allele frequency distribution 
observed in the data).  The distinct departure of observed points (black x-marks) above 
the green and blue lines represents a significant departure of some SNPs from the 
background level of population differentiation.  This can be seen by their departure from 
95% ‘concentration bands’ (14) indicated in grey, which mark out the approximate zone 
within which one would expect QQ plots to reside under the null hypothesis (which here 
has been adjusted to reflect expected Genomic Control inflation). 
 
The majority of SNPs at the top end of the QQ plot are found to come from the genomic 
region around EPAS1 (chr2:46400000..46900000, see Fig. S4). When SNPs from this 
genomic region are removed (Fig. S2), the QQ plot for the remaining autosomal SNPs is 
more in line with the 95% concentration band, although with enough departure above it 
to suggest further investigation and study would be warranted (see also “Enrichment of 
HIF pathway genes in sub-genome wide significant results” section in this Supporting 
Information).  
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We analyzed the X chromosome separately, and the resulting QQ plot is shown in Fig. 
S3.  We treat this chromosome separately because Genomic Control theory predicts the 
lambda to be less than that for autosomal SNPs.  Following the distributional theory 
provided by Devlin et al (2001), we expect nc+≈ 1λ , where n is the number of 
chromosomes sampled and c is a constant that depends on FST and inbreeding 
coefficients.  If nA is the number of autosomal chromosomes sampled, then nX = nA(gf + 
0.5gm), where nX is the number of X-chromosomes sampled, and gm and gf are 
respectively the frequencies of males and females sampled.  Thus, if we assumed that the 
underlying FST and inbreeding coefficients were the same for both autosomal and X-
chromosome loci, we would then predict )1)(5.0(1 −++≈ AmfX gg λλ , where λA and λX 
are the respective lambda values for autosomal and X-chromosome loci, and we could 
use that to construct an appropriately weighted joint analysis.  However, it is possible for 
sex-specific migration patterns to result in different background levels of FST for these 
two sets of loci.  For this reason, we have chosen to consider the X-chromosome 
separately.  Fig. S3 shows that there are no large signals of selection on the X-
chromosome indicated by our data. 
 
Enrichment of HIF Pathway Genes in Sub-Genome Wide Significant Results. In 
view of the role of EPAS1 as a core gene of the hypoxia-inducible factor transcription 
activation pathway, we investigated the other core genes of this pathway to determine 
whether they associate more than expected by chance with other regions of potential 
interest from the GWADS analysis. The set of core candidate genes was defined as: 
HIF1α, EPAS1, HIF3α, ARNT, EGLN1, EGLN2, EGLN3, HIF1AN and VHL. We then 
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defined a weak GWADS p-value cut-off of 5x10-4, corresponding approximately to the 
point in Fig. S2 at which the observed GWADS chi-square values among non-EPAS1 
autosomal SNPs showed some evidence of additional signals by dint of rising above the 
95% Q-Q plot concentration band.  This procedure produced a set of 375 non-EPAS1 
SNPs, as well as an expanded set of 31 SNPs in the EPAS1 region which spanned 
chr2:46420780-46863250 in Build 36 co-ordinates and covered most of the EPAS1 gene 
(chr2:46378067-46467340).  See Table S1 for a full list of these SNPs.  We excluded 
EPAS1 SNPs from further analysis, in order to ask the question of whether there was 
additional evidence of coincidence of GWADS signals with the other 8 genes in the core 
candidate gene set.  We defined a “GWADS signal region” to be +/-50kb around each of 
the 307 non-EPAS1 SNPs with a GWADS p-value <5x10-4.  SNPs within 50kb of each 
other were grouped in one region, and 180 regions were defined in this way, ranging in 
size from the defined minimum of 100 kb up to 302 kb and covering 22.2 Mb in total.  
We found that 2 of the 8 genes – HIF1α and EGLN3 – lay within a GWADS signal 
region.  The p-value for this coincidence, constructed from a null which assumes random 
placement of GWADS signal regions throughout the genome, is 0.0014.  We conclude 
that additional evidence exists for differential selection among other genes in the HIF 
pathway. 
 





1. Hoit BD, et al. (2006) Nitric oxide and cardiopulmonary hemodynamics in 
Tibetan highlanders. Journal of Applied Physiology 99:1796-1801. 
2. Erzurum SC, et al. (2007) Higher blood flow and circulating NO products offset 
high-altitude hypoxia among Tibetans. Proceedings of the National Academy of 
Sciences 104(45):17593. 
3. Lum A & Le Marchand L (1998) A simple mouthwash method for obtaining 
genomic DNA in molecular epidemiological studies. Cancer Epidemiol. 
Biomarkers Prev. 7(8):719-724. 
4. Zhao M, et al. (2009) Mitochondrial genome evidence reveals successful Late 
Paleolithic settlement on the Tibetan Plateau. PNAS 106(50):21230-21235. 
5. Shi H, et al. (2008) Y chromosome evidence of earliest modern human settlement 
in East Asia and multiple origins of Tibetan and Japanese populations. BMC Biol 
6:45. 
6. Purcell S, Cherny SS, & Sham PC (2003) Genetic Power Calculator: design of 
linkage and association genetic mapping studies of complex traits. Bioinformatics 
19(1):149-150. 
7. Holsinger KE & Weir BS (2009) Genetics in geographically structured 
populations: defining, estimating and interpreting F(ST). Nat Rev Genet 
10(9):639-650. 
  15 
 
8. Voight BF, Kudaravalli S, Wen X, & Pritchard JK (2006) A map of recent 
positive selection in the human genome. PLoS Biol 4(3):e72. 
9. Sasieni PD (1999) Statistical analysis of the performance of diagnostic tests. 
Cytopathology 10(2):73-78. 
10. Devlin B & Roeder K (1999) Genomic control for association studies. Biometrics 
55(4):997-1004. 
11. Devlin B, Roeder K, & Wasserman L (2001) Genomic control, a new approach to 
genetic-based association studies. Theor Popul Biol 60(3):155-166. 
12. Campbell CD, et al. (2005) Demonstrating stratification in a European American 
population. Nat Genet 37(8):868-872. 
13. Balding DJ & Nichols RA (1995) A method for quantifying differentiation 
between populations at multi-allelic loci and its implications for investigating 
identity and paternity. Genetica 96(1-2):3-12. 
14. Quesenberry CP & Hales C (1980) Concentration bands for uniformity plots. 
Journal of Statistical Computation and Simulation 11:41-53. 
 
 




Fig. S1. GWADS (Yunnan Tibetan sample vs HapMap Phase 3 Han sample) applied to 
all autosomal loci. The red line indicates where values are expected to fall if there is no 
population differentiation between these two samples.  The green line indicates where 
values are expected to fall if all loci were subject to the same level of background 
differentiation between the two samples, using genomic control theory and using the 
robust median method of Devlin & Roeder (10) to estimate lambda (here, 1.817).  The 
two blue lines represent a check on the validity of the genomic control result based on 
simulation. See SI Methods for further details. 
 
Fig. S2. GWADS (Yunnan Tibetan sample vs HapMap Phase 3 Han sample) applied to 
all autosomal loci minus the EPAS1 region. For rest of legend, see Fig. S1. 
 
Fig. S3. GWADS (Yunnan Tibetan sample vs HapMap Phase 3 Han sample) applied to 
X-chromosome loci only. For rest of legend, see Fig. S1. 
 
Fig. S4. Overview of chromosome 2 region containing the 8 GWADS significant SNPs. 
A: Annotation of region showing genomic context. B: -log10 of P values from GWADS 
between Han and Yunnan Tibetan populations. C: Pairwise r2 disequilibrium heat map in 
Yunnan sample. 
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Fig. S5. Pairwise r2 linkage disequilibrium between EPAS1 hemoglobin-associating 
SNPs. Pairwise LD values (r2) calculated between the 26 variants associating 
significantly with hemoglobin concentration in both the Mag Xiang and Zhaxizong Xiang 
populations. Darker shading indicates higher levels of LD.  
 
 
Table S1. Results for all autosomal SNPs from GWADS analysis with p-values 
<5x10-4. Bold rows indicate the 8 SNPs on chromosome 2 near EPAS1 with p-values 
<5x10-7.  These form part of a larger GWADS signal region (#8) overlapping with 
EPAS1 and containing 31 SNPs in total.  Columns are as follows.  SNP: dbSNP ID.  
CHR: chromosome. BP (B36):  base-pair position using NCBI Build 36.  Clust#:  
index of GWADS signal region, defined as SNPs in this list within 50kb of each 
other.   A1: Allele 1 (positive strand).  Fr(Yunnan): Frequency of Allele 1 in Yunnan 
sample.  Fr(Han): Frequency of Allele 1 in HapMap Phase 3 CHB sample.  A2: Allele 
2 (positive strand).  CHISQ: GWADS chi-square value after genomic control 
correction.  P: p-value of GWADS chi-square value. 
 
 
SNP CHR BP (B36) Clust# A1 Fr(Yunnan) Fr(Han) A2 CHISQ P 
rs9436520 1 55909833 1 G 0.657 0.289 A 15.393 8.73E-05 
rs2767503 1 55925313 1 G 0.657 0.286 T 15.786 7.09E-05 
rs1183736 1 55955751 1 C 0.657 0.321 A 12.649 3.76E-04 
rs3818637 1 63239243 2 G 0.500 0.131 A 20.445 6.14E-06 
rs17124399 1 63262571 2 T 0.500 0.139 C 19.200 1.18E-05 
rs1874930 1 63279983 2 C 0.614 0.280 A 13.008 3.10E-04 
rs11208115 1 63294343 2 C 0.614 0.280 T 13.008 3.10E-04 
rs7553832 1 75864015 3 G 0.229 0.030 A 13.435 2.47E-04 
rs1175128 1 190466177 4 C 0.557 0.241 T 12.228 4.71E-04 
rs1175106 1 190475536 4 T 0.471 0.165 C 13.401 2.51E-04 
rs946421 1 190478465 4 T 0.543 0.169 C 18.934 1.35E-05 
rs1175154 1 190496712 4 A 0.543 0.167 G 19.305 1.11E-05 
rs1175126 1 190502999 4 G 0.543 0.167 A 19.305 1.11E-05 
rs1175121 1 190513213 4 A 0.529 0.177 G 16.583 4.66E-05 
rs1175119 1 190515739 4 A 0.457 0.155 C 13.562 2.31E-04 
rs1339129 1 190549852 4 C 0.529 0.173 T 17.286 3.22E-05 
rs6663865 1 190562661 4 C 0.529 0.173 T 17.286 3.22E-05 
rs2284664 1 194969148 5 T 0.643 0.310 C 12.582 3.89E-04 
rs7551249 1 235328384 6 G 0.243 0.042 A 12.206 4.76E-04 
rs17026460 2 40738151 7 T 0.543 0.229 C 12.300 4.53E-04 
rs983123 2 40794120 7 A 0.543 0.232 G 12.062 5.15E-04 
rs1107932 2 40802672 7 C 0.543 0.232 T 12.062 5.15E-04 
rs4953353 2 46420780 8 G 0.686 0.345 T 12.831 3.41E-04 
rs6756667 2 46432913 8 A 0.500 0.131 G 20.445 6.14E-06 
rs7589621 2 46435886 8 G 0.643 0.274 A 15.770 7.15E-05 
rs7583554 2 46440601 8 T 0.629 0.238 C 18.254 1.93E-05 
rs3768729 2 46445510 8 T 0.614 0.256 C 15.211 9.62E-05 
SNP CHR BP (B36) Clust# A1 Fr(Yunnan) Fr(Han) A2 CHISQ P 
rs1374749 2 46449937 8 G 0.529 0.196 A 14.530 1.38E-04 
rs1992846 2 46451085 8 C 0.600 0.274 T 12.483 4.11E-04 
rs7583088 2 46456669 8 G 0.543 0.161 A 20.113 7.30E-06 
rs13019268 2 46463716 8 C 0.529 0.191 A 15.183 9.76E-05 
rs1868092 2 46467706 8 A 0.486 0.089 G 26.283 2.95E-07 
rs11689694 2 46470686 8 C 0.529 0.185 T 15.858 6.83E-05 
rs13011481 2 46489152 8 C 0.500 0.137 T 19.554 9.78E-06 
rs12615428 2 46489781 8 T 0.671 0.274 G 18.154 2.04E-05 
rs1447563 2 46490868 8 C 0.529 0.095 A 29.658 5.15E-08 
rs11125075 2 46509848 8 G 0.514 0.089 A 29.331 6.10E-08 
rs4953388 2 46566705 8 A 0.529 0.065 G 36.419 1.59E-09 
rs7590802 2 46576723 8 C 0.557 0.173 A 19.809 8.56E-06 
rs4953396 2 46590298 8 A 0.514 0.071 C 33.304 7.88E-09 
rs896210 2 46600249 8 G 0.629 0.161 A 28.590 8.95E-08 
rs1451156 2 46686106 8 T 0.543 0.163 C 19.737 8.89E-06 
rs1531133 2 46697135 8 G 0.543 0.167 A 19.305 1.11E-05 
rs982414 2 46699080 8 G 0.414 0.030 A 33.016 9.14E-09 
rs6735530 2 46701950 8 C 0.457 0.071 T 26.991 2.04E-07 
rs12105006 2 46716090 8 C 0.500 0.119 T 22.332 2.29E-06 
rs10495934 2 46728250 8 A 0.414 0.107 G 16.273 5.48E-05 
rs6712910 2 46730462 8 A 0.414 0.113 G 15.404 8.68E-05 
rs7596521 2 46772169 8 G 0.571 0.220 A 15.410 8.65E-05 
rs11676737 2 46783377 8 C 0.386 0.113 T 13.031 3.06E-04 
rs13025984 2 46792293 8 C 0.386 0.113 T 13.031 3.06E-04 
rs4952843 2 46811349 8 G 0.386 0.113 A 13.031 3.06E-04 
rs11125091 2 46863250 8 T 0.729 0.363 C 14.657 1.29E-04 
rs9750635 2 50890216 9 C 0.214 0.018 T 15.089 1.03E-04 
rs6741326 2 50982789 9 A 0.157 0.006 G 13.053 3.03E-04 
rs7558540 2 50993732 9 T 0.157 0.006 C 13.053 3.03E-04 
rs7423296 2 51002576 9 C 0.157 0.006 T 13.053 3.03E-04 
rs6749209 2 51092156 9 G 0.157 0.006 A 13.053 3.03E-04 
rs10166783 2 61870589 10 A 0.471 0.151 G 15.128 1.00E-04 
rs1534645 2 61880589 10 A 0.471 0.167 C 13.324 2.62E-04 
rs2178293 2 61887978 10 G 0.471 0.167 A 13.324 2.62E-04 
rs11688210 2 61890114 10 T 0.471 0.173 C 12.671 3.71E-04 
rs7589969 2 61897757 10 T 0.486 0.185 G 12.494 4.08E-04 
rs11125895 2 61922862 10 C 0.471 0.173 T 12.671 3.71E-04 
rs2272429 2 61961136 10 A 0.471 0.179 G 12.046 5.19E-04 
rs13391261 2 64509913 11 G 0.257 0.042 A 13.501 2.38E-04 
rs4671582 2 64514908 11 T 0.214 0.018 C 15.089 1.03E-04 
rs7591656 2 64516236 11 T 0.243 0.036 C 13.440 2.46E-04 
rs6733373 2 64519165 11 T 0.214 0.024 C 13.501 2.38E-04 
rs10496114 2 64521757 11 G 0.214 0.024 T 13.501 2.38E-04 
rs6729083 2 64534471 11 A 0.243 0.042 G 12.206 4.76E-04 
rs6743363 2 65898568 12 G 0.200 0.024 A 12.140 4.94E-04 
rs6740609 2 79709130 13 C 0.600 0.274 T 12.322 4.48E-04 
rs2974173 2 79975239 14 T 0.300 0.065 G 12.920 3.25E-04 
rs2974179 2 79991756 14 G 0.314 0.065 A 14.170 1.67E-04 
rs12619752 2 83283340 15 A 0.486 0.179 G 13.119 2.92E-04 
rs11126894 2 83289748 15 T 0.486 0.185 G 12.494 4.08E-04 
rs7422290 2 83325517 15 C 0.486 0.185 T 12.494 4.08E-04 
SNP CHR BP (B36) Clust# A1 Fr(Yunnan) Fr(Han) A2 CHISQ P 
rs7420983 2 83327662 15 C 0.486 0.183 T 12.527 4.01E-04 
rs6547469 2 83328343 15 G 0.486 0.185 A 12.494 4.08E-04 
rs6547479 2 83369435 15 C 0.414 0.125 A 13.789 2.05E-04 
rs12232909 2 83399672 15 A 0.486 0.177 G 13.163 2.85E-04 
rs7422781 2 83414351 15 A 0.486 0.155 G 15.880 6.75E-05 
rs6749875 2 83446361 15 G 0.486 0.161 A 15.150 9.93E-05 
rs10490697 2 105924977 16 G 0.329 0.071 A 14.414 1.47E-04 
rs1109164 2 105971618 16 A 0.500 0.191 G 12.948 3.20E-04 
rs1879494 2 108304947 17 A 0.386 0.054 C 23.494 1.25E-06 
rs12477830 2 108305167 17 A 0.357 0.072 G 16.721 4.33E-05 
rs7598552 2 108306502 17 C 0.371 0.054 T 22.022 2.70E-06 
rs12476238 2 108306768 17 T 0.329 0.071 C 14.414 1.47E-04 
rs10167564 2 108355057 17 A 0.300 0.048 G 16.273 5.48E-05 
rs4149432 2 108361757 17 G 0.300 0.048 T 16.273 5.48E-05 
rs4149436 2 108366218 17 C 0.300 0.048 T 16.273 5.48E-05 
rs4149437 2 108368055 17 C 0.229 0.030 T 13.435 2.47E-04 
rs4149438 2 108368480 17 A 0.300 0.048 C 16.273 5.48E-05 
rs13390901 2 108391443 17 T 0.257 0.048 G 12.333 4.45E-04 
rs6755756 2 108395088 17 G 0.257 0.048 A 12.333 4.45E-04 
rs12478500 2 108780535 18 T 0.257 0.036 C 14.785 1.21E-04 
rs1478515 2 108867361 18 C 0.243 0.042 T 12.206 4.76E-04 
rs4666885 2 183647418 19 C 0.300 0.054 T 15.072 1.03E-04 
rs2675043 2 183649689 19 C 0.186 0.006 T 15.958 6.48E-05 
rs11883456 2 183667706 19 G 0.200 0.006 A 17.225 3.32E-05 
rs2138484 2 183686187 19 G 0.314 0.065 A 14.170 1.67E-04 
rs2675058 2 183686794 19 G 0.229 0.006 A 20.428 6.19E-06 
rs2251775 2 183696844 19 C 0.200 0.012 T 15.426 8.58E-05 
rs1473617 2 183698108 19 C 0.229 0.012 T 18.359 1.83E-05 
rs6434006 2 183732947 19 T 0.200 0.012 C 15.426 8.58E-05 
rs1882443 2 183754364 19 T 0.200 0.012 C 15.426 8.58E-05 
rs10497624 2 183777265 19 T 0.314 0.077 C 12.234 4.69E-04 
rs987607 2 183777732 19 G 0.314 0.077 A 12.234 4.69E-04 
rs12617270 2 223654878 20 A 0.343 0.089 G 12.831 3.41E-04 
rs6717227 2 225722104 21 A 0.214 0.030 G 12.095 5.05E-04 
rs728654 2 225738376 21 G 0.214 0.030 T 12.095 5.05E-04 
rs7595272 2 228323996 22 C 0.329 0.083 T 12.522 4.02E-04 
rs489806 2 239764393 23 A 0.471 0.169 C 13.031 3.06E-04 
rs10208713 2 239853855 23 T 0.200 0.024 C 12.140 4.94E-04 
rs6737742 2 239880958 23 A 0.200 0.012 G 15.426 8.58E-05 
rs908262 2 239882459 23 A 0.200 0.012 C 15.426 8.58E-05 
rs925738 2 239906192 23 T 0.243 0.042 C 12.206 4.76E-04 
rs11686104 2 239951083 23 A 0.214 0.018 G 15.089 1.03E-04 
rs2170342 3 19957139 24 T 0.414 0.110 C 15.687 7.48E-05 
rs10510590 3 27155147 25 C 0.314 0.077 T 12.234 4.69E-04 
rs2029618 3 27453903 26 G 0.186 0.018 A 12.284 4.57E-04 
rs2724509 3 27699856 27 A 0.243 0.042 G 12.206 4.76E-04 
rs2642935 3 27701955 27 G 0.243 0.042 A 12.206 4.76E-04 
rs1494835 3 27704113 27 G 0.243 0.042 A 12.206 4.76E-04 
rs9848796 3 27713399 27 G 0.235 0.036 A 12.427 4.23E-04 
rs6791790 3 40025279 28 A 0.457 0.131 G 16.583 4.66E-05 
rs7632391 3 40055548 28 G 0.500 0.196 A 12.344 4.42E-04 
SNP CHR BP (B36) Clust# A1 Fr(Yunnan) Fr(Han) A2 CHISQ P 
rs6599081 3 40248504 29 A 0.343 0.077 G 14.674 1.28E-04 
rs2371136 3 40250659 29 T 0.343 0.077 C 14.674 1.28E-04 
rs17078914 3 40420122 30 G 0.314 0.060 A 15.249 9.42E-05 
rs9844316 3 40572524 31 C 0.671 0.333 T 12.577 3.91E-04 
rs7618923 3 45105729 32 T 0.214 0.024 C 13.501 2.38E-04 
rs555480 3 53470887 33 G 0.243 0.601 T 14.043 1.79E-04 
rs2036342 3 123773269 34 T 0.086 0.399 C 12.605 3.85E-04 
rs9858096 3 195401596 35 T 0.671 0.339 C 12.261 4.62E-04 
rs12233740 4 7202335 36 T 0.286 0.048 C 14.928 1.12E-04 
rs1370463 4 36388016 37 G 0.257 0.048 T 12.333 4.45E-04 
rs9306942 4 36659702 38 C 0.214 0.554 A 12.704 3.65E-04 
rs2703457 4 55179113 39 C 0.371 0.071 T 18.337 1.85E-05 
rs10003040 4 84998115 40 T 0.186 0.018 C 12.112 5.01E-04 
rs10021381 4 85009291 40 T 0.186 0.018 C 12.284 4.57E-04 
rs6843164 4 95838010 41 T 0.029 0.316 C 12.665 3.72E-04 
rs3805322 4 100276021 42 G 0.086 0.476 A 18.066 2.13E-05 
rs1442490 4 100545426 43 A 0.200 0.566 G 14.724 1.24E-04 
rs994772 4 100546687 43 T 0.500 0.191 C 12.948 3.20E-04 
rs994771 4 100546826 43 G 0.757 0.355 A 17.634 2.68E-05 
rs284793 4 100549317 43 G 0.771 0.381 A 16.677 4.43E-05 
rs284784 4 100554897 43 A 0.186 0.554 C 14.978 1.09E-04 
rs11734670 4 109705831 44 C 0.143 0.464 T 12.123 4.98E-04 
rs3796938 4 109730683 44 T 0.129 0.470 C 13.695 2.15E-04 
rs3796934 4 109761110 44 T 0.143 0.464 G 12.123 4.98E-04 
rs6533371 4 109766466 44 C 0.100 0.423 T 12.914 3.26E-04 
rs11097999 4 109772330 44 G 0.143 0.464 A 12.123 4.98E-04 
rs1483414 4 127344347 45 A 0.414 0.139 C 12.057 5.16E-04 
rs4834101 4 127379201 45 C 0.414 0.137 T 12.317 4.49E-04 
rs7694604 4 146649743 46 G 0.400 0.065 T 22.332 2.29E-06 
rs7662541 4 146654130 46 T 0.357 0.048 C 21.933 2.82E-06 
rs7698944 4 146655801 46 G 0.400 0.060 A 23.278 1.40E-06 
rs2043779 4 146667239 46 C 0.357 0.060 T 19.305 1.11E-05 
rs7670486 4 146673371 46 A 0.357 0.048 G 21.933 2.82E-06 
rs6848760 4 146704447 46 A 0.400 0.077 C 19.958 7.92E-06 
rs7668932 4 160369325 47 T 0.257 0.042 C 13.501 2.38E-04 
rs4691761 4 162581923 48 T 0.700 0.343 G 14.004 1.82E-04 
rs7696087 4 167101629 49 G 0.657 0.327 A 12.173 4.85E-04 
rs6851885 4 176510445 50 A 0.243 0.024 G 16.306 5.39E-05 
rs6842506 4 176569534 50 T 0.271 0.042 G 14.608 1.32E-04 
rs4975807 5 2085660 51 C 0.543 0.202 T 15.023 1.06E-04 
rs6555046 5 2109586 51 G 0.500 0.179 A 14.231 1.62E-04 
rs4975727 5 2111143 51 G 0.500 0.196 A 12.344 4.42E-04 
rs4701260 5 25994662 52 G 0.500 0.199 A 12.051 5.18E-04 
rs35408 5 34000695 53 T 0.729 0.381 C 13.230 2.76E-04 
rs1423431 5 37965715 54 C 0.400 0.119 T 13.401 2.51E-04 
rs3797246 5 53546258 55 A 0.157 0.006 G 13.053 3.03E-04 
rs13355401 5 58330116 56 G 0.243 0.036 A 13.440 2.46E-04 
rs1546221 5 58338737 56 A 0.243 0.037 G 13.031 3.06E-04 
rs4479801 5 58340256 56 T 0.243 0.036 C 13.235 2.75E-04 
rs7719726 5 59985294 57 T 0.574 0.238 C 13.329 2.61E-04 
rs4298206 5 60047992 57 C 0.514 0.202 T 12.809 3.45E-04 
SNP CHR BP (B36) Clust# A1 Fr(Yunnan) Fr(Han) A2 CHISQ P 
rs17237251 5 67447959 58 C 0.171 0.500 T 12.267 4.61E-04 
rs2888306 5 67448240 58 T 0.514 0.149 C 19.161 1.20E-05 
rs6449947 5 67452165 58 C 0.443 0.125 T 16.179 5.76E-05 
rs13176053 5 67459042 58 A 0.514 0.155 G 18.342 1.85E-05 
rs897316 5 67472151 58 C 0.543 0.169 T 18.934 1.35E-05 
rs4277860 5 67511708 58 G 0.114 0.435 A 12.488 4.09E-04 
rs12521058 5 76462743 59 A 0.386 0.107 C 13.838 1.99E-04 
rs10052560 5 76466058 59 A 0.386 0.107 G 13.838 1.99E-04 
rs12655063 5 76901725 60 A 0.357 0.083 C 14.962 1.10E-04 
rs7732591 5 142105361 61 C 0.643 0.316 T 12.095 5.05E-04 
rs930208 5 142111334 61 A 0.643 0.316 G 12.095 5.05E-04 
rs1549896 5 144242936 62 A 0.257 0.042 G 13.501 2.38E-04 
rs1368335 5 144255438 62 T 0.243 0.042 G 12.206 4.76E-04 
rs10043401 5 155722608 63 C 0.200 0.024 A 12.140 4.94E-04 
rs9296345 6 12406319 64 T 0.171 0.012 C 12.566 3.93E-04 
rs7356986 6 12409448 64 A 0.171 0.006 G 14.497 1.40E-04 
rs16872601 6 12410884 64 T 0.171 0.006 G 14.497 1.40E-04 
rs6925906 6 12467288 64 A 0.171 0.012 G 12.400 4.29E-04 
rs12212807 6 12628644 65 T 0.186 0.018 G 12.284 4.57E-04 
rs2516225 6 12712441 65 A 0.443 0.145 G 13.562 2.31E-04 
rs1800683 6 31648050 66 A 0.343 0.080 G 13.916 1.91E-04 
rs16883137 6 34357524 67 A 0.243 0.042 G 12.206 4.76E-04 
rs1057691 6 34407210 67 G 0.243 0.042 A 12.206 4.76E-04 
rs495433 6 71663708 68 T 0.729 0.390 C 12.433 4.22E-04 
rs164301 6 94086536 69 T 0.686 0.351 G 12.367 4.37E-04 
rs4336470 6 105287478 70 T 0.500 0.187 C 13.269 2.70E-04 
rs9404576 6 105291333 70 G 0.500 0.179 T 14.231 1.62E-04 
rs9322816 6 105323388 70 C 0.471 0.173 T 12.671 3.71E-04 
rs6911031 6 105418309 70 T 0.443 0.125 C 16.179 5.76E-05 
rs6928554 6 105439613 70 C 0.486 0.173 T 13.772 2.06E-04 
rs2858829 6 116875610 71 G 0.171 0.566 A 17.153 3.45E-05 
rs9400918 6 116901221 71 T 0.186 0.579 C 16.920 3.90E-05 
rs6568960 6 117097203 72 G 0.686 0.327 A 14.303 1.56E-04 
rs6570048 6 136240287 73 T 0.729 0.387 C 12.776 3.51E-04 
rs3778303 6 136790759 74 T 0.343 0.083 C 13.722 2.12E-04 
rs9389496 6 137753928 75 G 0.186 0.518 A 12.378 4.34E-04 
rs9321599 6 137760226 75 A 0.186 0.518 G 12.378 4.34E-04 
rs408901 6 137913285 76 G 0.214 0.030 A 12.095 5.05E-04 
rs2689420 7 6376846 77 A 0.371 0.108 G 12.422 4.24E-04 
rs836556 7 6413566 77 A 0.400 0.119 G 13.401 2.51E-04 
rs13238780 7 6448149 77 A 0.400 0.119 G 13.401 2.51E-04 
rs4537216 7 16350385 78 T 0.357 0.095 G 13.152 2.87E-04 
rs12700439 7 23438586 79 C 0.371 0.084 T 15.952 6.50E-05 
rs10247175 7 30872400 80 A 0.486 0.185 C 12.494 4.08E-04 
rs3801324 7 30878532 80 A 0.586 0.256 C 13.020 3.08E-04 
rs7805350 7 30895999 80 T 0.586 0.259 C 12.682 3.69E-04 
rs1203181 7 30897832 80 C 0.586 0.256 T 13.020 3.08E-04 
rs1525240 7 46771438 81 A 0.357 0.101 G 12.322 4.48E-04 
rs4437575 7 86977252 82 G 0.400 0.113 A 14.198 1.65E-04 
rs10260551 7 88597357 83 C 0.643 0.298 T 13.589 2.27E-04 
rs2040677 7 88602354 83 G 0.643 0.298 A 13.589 2.27E-04 
SNP CHR BP (B36) Clust# A1 Fr(Yunnan) Fr(Han) A2 CHISQ P 
rs7357193 7 93625349 84 A 0.400 0.125 C 12.649 3.76E-04 
rs10273354 7 115261201 85 G 0.214 0.024 A 13.501 2.38E-04 
rs7783740 7 115272981 85 G 0.214 0.024 T 13.501 2.38E-04 
rs2059645 8 18862537 86 A 0.329 0.042 G 20.428 6.19E-06 
rs4921978 8 18880825 86 T 0.471 0.131 C 17.839 2.40E-05 
rs11987117 8 18882220 86 A 0.471 0.125 G 18.708 1.52E-05 
rs7010496 8 18910648 86 T 0.243 0.024 C 16.306 5.39E-05 
rs890519 8 18949329 86 A 0.400 0.119 C 13.401 2.51E-04 
rs1506895 8 18953838 86 G 0.386 0.113 A 13.031 3.06E-04 
rs7813420 8 21922030 87 C 0.314 0.065 A 14.170 1.67E-04 
rs11776272 8 21940490 87 G 0.457 0.139 A 15.471 8.38E-05 
rs10089142 8 21947885 87 G 0.386 0.095 A 15.581 7.90E-05 
rs1442341 8 26666344 88 T 0.257 0.048 C 12.333 4.45E-04 
rs2730145 8 40403937 89 G 0.271 0.042 A 14.834 1.17E-04 
rs13278529 8 40452478 89 G 0.214 0.030 T 12.095 5.05E-04 
rs10091962 8 40482035 89 C 0.229 0.030 T 13.435 2.47E-04 
rs12676394 8 96853702 90 A 0.571 0.229 C 14.442 1.45E-04 
rs2386931 8 102226038 91 T 0.371 0.072 C 18.044 2.16E-05 
rs11990866 8 102234459 91 C 0.357 0.071 T 16.998 3.74E-05 
rs7011529 8 102261354 91 G 0.386 0.089 A 16.533 4.78E-05 
rs1947124 8 102321808 91 C 0.371 0.095 T 14.353 1.52E-04 
rs1529605 8 102330867 91 T 0.500 0.173 C 14.906 1.13E-04 
rs4734825 8 105947823 92 T 0.100 0.458 G 15.371 8.83E-05 
rs10094493 8 105948008 92 T 0.100 0.458 C 15.371 8.83E-05 
rs2880438 8 106345899 93 G 0.457 0.161 A 12.887 3.31E-04 
rs2941627 8 106352206 93 G 0.171 0.012 A 12.566 3.93E-04 
rs2447243 8 108009844 94 A 0.543 0.214 G 13.778 2.06E-04 
rs1462014 8 108078089 94 T 0.414 0.137 C 12.317 4.49E-04 
rs2844234 8 110651542 95 G 0.643 0.313 A 12.228 4.71E-04 
rs7461495 8 130795207 96 A 0.186 0.006 G 15.958 6.48E-05 
rs3885952 8 130811926 96 T 0.186 0.006 C 15.958 6.48E-05 
rs4606023 8 130824575 96 T 0.186 0.012 G 13.988 1.84E-04 
rs1600934 8 130855919 96 G 0.186 0.012 A 13.988 1.84E-04 
rs2086639 8 130878870 96 C 0.200 0.006 T 17.435 2.97E-05 
rs2085925 8 141003987 97 T 0.229 0.036 C 12.123 4.98E-04 
rs10814906 9 4260669 98 G 0.500 0.181 A 13.916 1.91E-04 
rs10814908 9 4262449 98 C 0.500 0.191 T 12.948 3.20E-04 
rs1359099 9 10401338 99 A 0.529 0.185 G 15.858 6.83E-05 
rs932638 9 84581506 100 C 0.457 0.131 A 16.583 4.66E-05 
rs963727 9 84595822 100 A 0.457 0.152 G 13.678 2.17E-04 
rs4877406 9 89950625 101 T 0.486 0.179 C 13.119 2.92E-04 
rs10868716 9 89952328 101 G 0.314 0.060 A 15.249 9.42E-05 
rs4077800 9 91487988 102 T 0.200 0.024 C 12.140 4.94E-04 
rs2779524 9 100378676 103 T 0.257 0.042 C 13.501 2.38E-04 
rs2808538 9 100384530 103 T 0.257 0.042 C 13.501 2.38E-04 
rs2778908 9 100385599 103 G 0.257 0.042 A 13.501 2.38E-04 
rs13289749 9 109690303 104 C 0.357 0.101 T 12.322 4.48E-04 
rs4979418 9 116303904 105 G 0.157 0.482 A 12.178 4.83E-04 
rs10983487 9 118863872 106 C 0.200 0.572 T 15.194 9.70E-05 
rs10984440 9 121009171 107 T 0.414 0.089 G 19.161 1.20E-05 
rs10818288 9 121028720 107 T 0.586 0.262 G 12.488 4.09E-04 
SNP CHR BP (B36) Clust# A1 Fr(Yunnan) Fr(Han) A2 CHISQ P 
rs1332445 9 121032095 107 C 0.400 0.089 T 17.833 2.41E-05 
rs10818289 9 121033329 107 T 0.586 0.256 C 13.020 3.08E-04 
rs1332448 9 121073287 107 C 0.300 0.065 T 12.920 3.25E-04 
rs17534 9 121074859 107 C 0.300 0.065 T 12.920 3.25E-04 
rs7026551 9 122772954 108 C 0.443 0.155 A 12.461 4.16E-04 
rs11255635 10 8410635 109 C 0.357 0.078 T 15.681 7.50E-05 
rs7905537 10 34271281 110 C 0.557 0.232 A 13.108 2.94E-04 
rs2673432 10 79149125 111 G 0.271 0.048 A 13.617 2.24E-04 
rs12761718 10 79162976 111 T 0.257 0.048 C 12.333 4.45E-04 
rs17417617 10 79163352 111 C 0.257 0.048 A 12.333 4.45E-04 
rs10786352 10 99261271 112 T 0.229 0.030 C 13.435 2.47E-04 
rs11592144 10 99273052 112 G 0.229 0.036 T 12.123 4.98E-04 
rs508001 10 99744963 113 C 0.457 0.131 A 16.583 4.66E-05 
rs1867075 10 99789814 113 G 0.329 0.077 A 13.435 2.47E-04 
rs11200014 10 123324920 114 A 0.571 0.250 G 12.510 4.05E-04 
rs2936540 10 126737532 115 C 0.029 0.323 A 13.103 2.95E-04 
rs1011476 11 2255611 116 T 0.286 0.060 G 12.699 3.66E-04 
rs7925089 11 3087994 117 T 0.186 0.012 G 13.988 1.84E-04 
rs10835093 11 26977037 118 T 0.500 0.185 C 13.578 2.29E-04 
rs10767734 11 28598957 119 C 0.529 0.214 T 12.699 3.66E-04 
rs11030393 11 28605313 119 A 0.557 0.191 G 17.562 2.78E-05 
rs7942414 11 28626540 119 T 0.543 0.161 C 20.113 7.30E-06 
rs4923554 11 28633414 119 A 0.557 0.202 G 16.179 5.76E-05 
rs7119404 11 28647863 119 C 0.571 0.185 T 19.554 9.78E-06 
rs939505 11 28670715 119 C 0.529 0.220 A 12.134 4.95E-04 
rs10835395 11 28697712 119 C 0.443 0.149 A 13.136 2.90E-04 
rs294374 11 30585114 120 A 0.529 0.213 G 12.660 3.74E-04 
rs294335 11 30627880 120 C 0.529 0.205 T 13.578 2.29E-04 
rs11824690 11 61896043 121 T 0.600 0.277 G 12.145 4.92E-04 
rs11231073 11 61917900 121 T 0.614 0.286 G 12.499 4.07E-04 
rs4963412 11 62937091 122 A 0.200 0.012 G 15.028 1.06E-04 
rs1791554 11 91941298 123 A 0.429 0.143 C 12.726 3.61E-04 
rs1783689 11 99986861 124 A 0.686 0.325 C 14.264 1.59E-04 
rs11217806 11 119675172 125 T 0.643 0.316 C 12.095 5.05E-04 
rs11605702 11 122416301 126 T 0.214 0.030 G 12.095 5.05E-04 
rs9919607 11 133954457 127 A 0.357 0.095 G 13.152 2.87E-04 
rs7127211 11 134197302 128 A 0.157 0.006 G 13.053 3.03E-04 
rs2846186 11 134203586 128 C 0.314 0.071 T 13.169 2.85E-04 
rs2846154 11 134219845 128 T 0.329 0.065 C 15.454 8.45E-05 
rs1892987 11 134220987 128 C 0.329 0.065 T 15.454 8.45E-05 
rs2846142 11 134223305 128 A 0.329 0.065 G 15.454 8.45E-05 
rs2661969 11 134223427 128 C 0.329 0.065 T 15.454 8.45E-05 
rs2368785 12 130943 129 C 0.271 0.054 T 12.499 4.07E-04 
rs7955668 12 134100 129 C 0.171 0.006 T 14.497 1.40E-04 
rs628121 12 158410 129 C 0.186 0.012 A 13.805 2.03E-04 
rs10505997 12 26420509 130 C 0.371 0.107 T 12.671 3.71E-04 
rs7962560 12 41573955 131 C 0.229 0.560 T 12.057 5.16E-04 
rs10785395 12 41591026 131 C 0.229 0.566 A 12.472 4.13E-04 
rs7303573 12 43805822 132 A 0.600 0.265 C 13.197 2.80E-04 
rs771997 12 50644435 133 A 0.714 0.333 G 16.063 6.13E-05 
rs2641530 12 50671078 133 C 0.714 0.333 T 16.063 6.13E-05 
SNP CHR BP (B36) Clust# A1 Fr(Yunnan) Fr(Han) A2 CHISQ P 
rs877869 12 50678467 133 A 0.700 0.333 G 14.912 1.13E-04 
rs1947021 12 52587052 134 G 0.471 0.149 A 15.438 8.53E-05 
rs10784600 12 65623079 135 A 0.657 0.327 G 12.173 4.85E-04 
rs9142 12 102691534 136 A 0.457 0.155 G 13.562 2.31E-04 
rs10861099 12 102699705 136 A 0.457 0.155 G 13.562 2.31E-04 
rs7296900 12 102701798 136 T 0.457 0.155 C 13.562 2.31E-04 
rs7487808 12 128508669 137 C 0.214 0.024 T 13.501 2.38E-04 
rs2218722 13 38171153 138 C 0.171 0.513 A 12.970 3.17E-04 
rs415484 13 39517078 139 C 0.114 0.435 A 12.488 4.09E-04 
rs1760854 13 66886043 140 T 0.171 0.012 C 12.566 3.93E-04 
rs1937503 13 66917885 140 C 0.186 0.012 T 13.988 1.84E-04 
rs11618001 13 66975757 140 A 0.157 0.006 G 12.566 3.93E-04 
rs12430627 13 67009053 140 G 0.186 0.006 A 15.958 6.48E-05 
rs9599553 13 69605722 141 T 0.186 0.518 C 12.378 4.34E-04 
rs167255 13 69606706 141 A 0.143 0.506 G 15.028 1.06E-04 
rs7320723 13 96727155 142 A 0.314 0.049 G 17.120 3.51E-05 
rs1325372 13 107431712 143 C 0.457 0.161 T 12.887 3.31E-04 
rs9514775 13 107440306 143 C 0.457 0.161 A 12.887 3.31E-04 
rs12871532 13 107466548 143 T 0.614 0.244 C 16.411 5.10E-05 
rs1223978 13 107573163 144 T 0.529 0.214 C 12.699 3.66E-04 
rs3212240 14 23880738 145 T 0.343 0.089 C 12.831 3.41E-04 
rs2295298 14 23913460 145 C 0.357 0.095 T 13.152 2.87E-04 
rs11628929 14 23913894 145 G 0.357 0.095 A 13.152 2.87E-04 
rs3742517 14 23917791 145 T 0.357 0.095 C 13.152 2.87E-04 
rs958722 14 33527765 146 G 0.400 0.119 A 13.401 2.51E-04 
rs1956157 14 39207151 147 G 0.729 0.381 T 13.230 2.76E-04 
rs2749494 14 39247057 147 G 0.700 0.363 A 12.483 4.11E-04 
rs1953192 14 39367290 148 T 0.100 0.423 G 12.914 3.26E-04 
rs1547809 14 46602004 149 C 0.386 0.113 T 13.031 3.06E-04 
rs17099239 14 61337261 150 G 0.271 0.054 A 12.499 4.07E-04 
rs171457 14 62375298 151 A 0.221 0.574 G 13.296 2.66E-04 
rs17116370 14 81664830 152 C 0.186 0.018 A 12.284 4.57E-04 
rs2305252 15 25940933 153 T 0.543 0.226 C 12.616 3.83E-04 
rs3829488 15 25950281 153 G 0.743 0.313 T 20.401 6.28E-06 
rs8043226 15 43108885 154 A 0.200 0.024 G 12.140 4.94E-04 
rs269866 15 43181698 154 G 0.357 0.089 A 14.032 1.80E-04 
rs175088 15 43200964 154 A 0.257 0.036 G 14.785 1.21E-04 
rs2203646 15 44671528 155 A 0.643 0.268 G 16.157 5.83E-05 
rs11071175 15 53347717 156 A 0.557 0.229 G 13.352 2.58E-04 
rs12902710 15 53398418 156 T 0.571 0.226 C 14.790 1.20E-04 
rs678892 15 53420151 156 G 0.571 0.226 T 14.790 1.20E-04 
rs34979470 15 54150990 157 G 0.600 0.265 A 13.197 2.80E-04 
rs8038056 15 97300451 158 G 0.629 0.280 A 14.087 1.75E-04 
rs2684796 15 97300915 158 T 0.629 0.283 C 13.722 2.12E-04 
rs276968 16 84789677 159 G 0.186 0.530 T 13.213 2.78E-04 
rs11866010 16 85261897 160 A 0.243 0.589 C 13.136 2.90E-04 
rs2411979 17 44782242 161 A 0.543 0.191 G 16.350 5.26E-05 
rs11655704 17 44803171 161 C 0.686 0.268 T 20.052 7.54E-06 
rs1385033 18 33992206 162 G 0.157 0.006 A 13.053 3.03E-04 
rs17551764 18 34009759 162 T 0.157 0.006 C 13.053 3.03E-04 
rs1789094 18 72975173 163 T 0.457 0.161 C 12.887 3.31E-04 
SNP CHR BP (B36) Clust# A1 Fr(Yunnan) Fr(Han) A2 CHISQ P 
rs9951586 18 72986306 163 C 0.486 0.179 T 13.119 2.92E-04 
rs1667952 18 72986962 163 G 0.486 0.179 A 13.119 2.92E-04 
rs10414066 19 2012715 164 T 0.243 0.042 C 12.206 4.76E-04 
rs10407399 19 4960466 165 T 0.271 0.048 G 13.617 2.24E-04 
rs8106598 19 56709752 166 T 0.343 0.089 C 12.831 3.41E-04 
rs16981118 20 19712816 167 C 0.214 0.030 A 12.095 5.05E-04 
rs6072163 20 38910366 168 A 0.343 0.083 G 13.722 2.12E-04 
rs2868767 20 44258031 169 G 0.529 0.220 A 12.134 4.95E-04 
rs913879 20 55893340 170 G 0.200 0.012 A 15.426 8.58E-05 
rs1374957 20 57522349 171 C 0.300 0.048 T 16.273 5.48E-05 
rs2244105 21 15375227 172 A 0.214 0.030 G 12.095 5.05E-04 
rs1387616 21 19749070 173 A 0.314 0.077 G 12.234 4.69E-04 
rs2825590 21 19750385 173 G 0.314 0.077 A 12.234 4.69E-04 
rs2832499 21 30238880 174 G 0.143 0.494 A 14.121 1.71E-04 
rs2833795 21 32677634 175 G 0.129 0.452 A 12.488 4.09E-04 
rs2838567 21 44718335 176 T 0.286 0.054 C 13.772 2.06E-04 
rs2213769 22 25571464 177 A 0.257 0.048 G 12.333 4.45E-04 
rs4141436 22 31967087 178 T 0.243 0.024 C 16.306 5.39E-05 
rs9611528 22 39978448 179 C 0.243 0.577 T 12.261 4.62E-04 
rs2235852 22 39991100 179 T 0.243 0.577 G 12.261 4.62E-04 
rs4823406 22 43663734 180 G 0.243 0.042 A 12.206 4.76E-04 
rs5771086 22 48937969 181 T 0.129 0.446 C 12.095 5.05E-04 
 
 
Table S2.  Average age and hemoglobin concentrations for Mag Xiang 
(4200m) and Zhaxizong Xiang (4300m) men and women. 
 
 
  Mag Xiang 
(4200m, n=72) 
Zhaxizong Xiang  
(4300m, n=91) 
 Variable N Mean±SD N Mean±SD 
Age, years 22 32.8±9.1 34 34.1±9.0 Males 
Hb, gm/dL 21 16.6±1.6 34 17.4±1.5 
Age, years 50 31.0±11.4 57 38.2 + 10.4 Females 
Hb, gm/dL 49 14.8±1.0 57 15.0±1.5 
Table S3. EPAS1 SNPs that are significantly associated with hemoglobin concentration 
(FDR<0.05) after adjusting for sex in two Tibetan samples at 4200-4300m. HbI-AF: 
Hemoglobin increasing allele frequency. P value: uncorrected P value of the likelihood 
ratio test. P FDR: P value corrected for false discovery rate. Est of Diff (95% CI): 
Estimated difference in hemoglobin concentration between major allele homozygotes 
(lower concentrations) and heterozygotes (higher concentrations), with 95% confidence 
interval (CI) in parentheses. See "EPAS1 association with hemoglobin concentration" 
above for full description of methodology. 
 
Mag Xiang Sample Zhaxizong Xiang Sample SNP Position major 
allele/minor 
allele 
HbI-AF Pvalue FDR Est of Diff 
(95% CI) 
HbI-AF Pvalue FDR Est of Diff 
(95% CI) 
rs11125068 46381319 G/A 21.5    15.9 <10-3 0.001 1.02(0.46,1.58) 
rs1867784 46387723 T/C 6.2 0.030 0.048 0.93(0.09,1.77)     
rs2121266 46389427 A/C 21.5    17 <10-3 0.001 1.02(0.47,1.57) 
rs17034950 46392297 G/A 20.8    17 <10-3 0.001 1.02(0.47,1.57) 
rs11689011 46394679 T/C 9 0.031 0.048 0.79(0.07,1.51)     
rs9973653 46401612 G/T 38.9    47.8 0.033 0.046 0.52(0.04,0.99) 
rs10193827 46403036 T/C 33.3 0.029 0.048 0.34(0.03,0.65) 11.5 <10-3 0.001 1.18(0.61,1.75) 
rs7582701 46404272 C/G 17.4 0.004 0.011 0.78(0.25,1.31) 11 0.001 0.002 1.04(0.45,1.63) 
rs4953342 46405550 A/G 15.3 0.011 0.026 0.74(0.17,1.31) 10.6 <10-3 0.002 1.05(0.46,1.63) 
rs4953343 46405680 G/C 17.4 0.004 0.011 0.78(0.25,1.31) 11 <10-3 0.001 1.13(0.55,1.71) 
rs13419896 46409848 A/G 15.3 0.028 0.048 0.62(0.07,1.18) 12.1 <10-3 0.001 1.21(0.65,1.77) 
rs9679290 46411147 G/C 14.6    11.5 <10-3 0.001 1.2(0.64,1.77) 
rs4953353 46420779 G/T 14.6 <10-3 0.006 0.97(0.43,1.5)     
rs4953354 46428891 G/A 16 <10-3 0.006 1.01(0.46,1.56) 15.4 0.003 0.005 0.84(0.28,1.39) 
rs6715787 46429675 C/G 15.3 0.003 0.011 0.87(0.3,1.45) 12.6 0.002 0.003 0.92(0.34,1.49) 
rs17035010 46429991 C/T 14.6 0.013 0.030 0.75(0.16,1.35) 12.6 0.002 0.003 0.92(0.34,1.49) 
rs17035013 46430076 T/C 15.3 0.003 0.011 0.87(0.3,1.45) 12.6 0.002 0.003 0.92(0.34,1.49) 
rs6544887 46430715 T/C 16.7 0.005 0.013 0.79(0.24,1.33) 16.5    
rs4953357 46432776 G/A 16 <10-3 0.006 1.01(0.46,1.56) 15.4 0.003 0.005 0.84(0.28,1.39) 
rs6756667 46432912 A/G 17.4 0.001 0.008 0.89(0.36,1.42) 13.2 0.001 0.002 0.96(0.39,1.52) 
rs1562453 46433977 T/C 16.7 0.001 0.006 0.92(0.4,1.45) 13.2 0.001 0.002 0.96(0.39,1.52) 
rs6712143 46436394 A/G 14.6 0.002 0.009 0.92(0.35,1.49) 13.2 0.001 0.002 0.96(0.39,1.52) 
rs7583554 46440600 T/C 14.6 0.002 0.009 0.92(0.35,1.49) 13.2 0.001 0.002 0.96(0.39,1.52) 
rs3768729 46445509 T/C 16.7 0.010 0.025 0.74(0.18,1.3) 13.2 0.004 0.006 0.85(0.28,1.42) 
rs10206434 46447039 A/G 22.2 0.001 0.007 0.84(0.35,1.32) 18.7 0.001 0.003 0.82(0.32,1.31) 
rs1374749 46449936 G/A 16 0.002 0.009 0.84(0.31,1.37) 13.2 0.002 0.003 0.91(0.34,1.48) 
rs1992846 46451084 C/T 12.5 0.022 0.043 0.67(0.1,1.25) 12.6 0.002 0.003 1.01(0.38,1.65) 
rs7565341 46452533 G/A 16 0.002 0.009 0.84(0.31,1.37) 15.9 0.013 0.019 0.71(0.15,1.26) 
rs12467821 46454397 C/T 15.3 0.003 0.011 0.8(0.27,1.33) 14.8 <10-3 0.001 1.03(0.49,1.58) 
rs11675441 46454999 T/C 15.3 0.003 0.011 0.8(0.27,1.33) 14.8 <10-3 0.001 1.03(0.49,1.58) 
rs7583088 46456668 G/A 15.3 0.003 0.011 0.8(0.27,1.33) 14.8 <10-3 0.001 1.03(0.49,1.58) 
rs11678465 46456763 T/C 18.1 0.010 0.025 0.66(0.16,1.16) 14.8 <10-3 0.001 1.03(0.49,1.58) 
rs7557402 46457174 G/C 21.5 0.022 0.043 0.55(0.08,1.02) 16.5 <10-3 0.002 0.96(0.43,1.5) 
rs7594278 46458096 T/G 22.2 0.029 0.048 0.52(0.05,0.99)     
rs7571218 46459162 G/A 18.1 0.024 0.046 0.57(0.07,1.06) 12.6 0.008 0.012 0.84(0.22,1.45) 
rs13006131 46462045 G/C 19.4 0.016 0.034 0.6(0.11,1.08) 16.5 <10-3 0.002 0.96(0.43,1.5) 
rs7590087 46464183 C/A 20.8    12.6 0.008 0.012 0.84(0.22,1.45) 
 
Table S4. Relationship between the 8 GWADS significant SNPs, the hemoglobin 
associating SNPs in EPAS1 and hemoglobin (Hb) in Mag Xiang and Zhaxizong 
Xiang cohorts. “Best proxy” represents the hemoglobin associating SNP in EPAS1 
with the highest r2 value for each of the 8 GWADS significant SNPs. P values are 
uncorrected from likelihood ratio test (see methods above). * Calculated in subset of 

















P value for correlation of 
GWADS SNP with Hb 
rs1868092 rs13006131 1 0.016 3.39 x 10-4 
rs1447563 rs13006131 1 0.016 0.0264 
rs11125075 rs7557402 1 0.022 0.014 
rs4953388 rs13006131 1 0.016 0.073 
rs4953396 rs13006131 0.84 0.016 0.073 
rs896210 rs1992846 0.89 0.022 0.088 
rs982414 rs10206434 0.55 0.001 0.296 
rs6735530 rs10206434 0.88 0.001 0.296 
 
 
 
 
 
 
